413 related articles for article (PubMed ID: 26051516)
21. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
22. Porcine circovirus type 2 (PCV2) genotyping in Austrian pigs in the years 2002 to 2017.
Weissenbacher-Lang C; Kristen T; Mendel V; Brunthaler R; Schwarz L; Weissenböck H
BMC Vet Res; 2020 Jun; 16(1):198. PubMed ID: 32539835
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2).
Beach NM; Meng XJ
Virus Res; 2012 Mar; 164(1-2):33-42. PubMed ID: 22005075
[TBL] [Abstract][Full Text] [Related]
24. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms.
Takahagi Y; Toki S; Nishiyama Y; Morimatsu F; Murakami H
J Vet Med Sci; 2010 Jan; 72(1):35-41. PubMed ID: 19915335
[TBL] [Abstract][Full Text] [Related]
26. Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2.
Huang LP; Lu YH; Wei YW; Guo LJ; Liu CM
BMC Microbiol; 2011 Aug; 11():188. PubMed ID: 21859462
[TBL] [Abstract][Full Text] [Related]
27. Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs.
Opriessnig T; Xiao CT; Gerber PF; Halbur PG; Matzinger SR; Meng XJ
J Gen Virol; 2014 Nov; 95(Pt 11):2495-2503. PubMed ID: 25053562
[TBL] [Abstract][Full Text] [Related]
28. Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis.
Trible BR; Rowland RR
Virus Res; 2012 Mar; 164(1-2):68-77. PubMed ID: 22198217
[TBL] [Abstract][Full Text] [Related]
29. Efficacy in pigs of a new inactivated vaccine combining porcine circovirus type 2 and Mycoplasma hyorhinis.
Wei YW; Zhu HZ; Huang LP; Xia DL; Wu HL; Bian HQ; Feng L; Liu CM
Vet Microbiol; 2020 Mar; 242():108588. PubMed ID: 32122592
[TBL] [Abstract][Full Text] [Related]
30. Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs.
Gerber PF; Johnson J; Shen H; Striegel D; Xiao CT; Halbur PG; Opriessnig T
Res Vet Sci; 2013 Oct; 95(2):775-81. PubMed ID: 23829995
[TBL] [Abstract][Full Text] [Related]
31. Genetic variability of porcine circovirus 2 (PCV2) field isolates from vaccinated and non-vaccinated pig herds in Germany.
Reiner G; Hofmeister R; Willems H
Vet Microbiol; 2015 Oct; 180(1-2):41-8. PubMed ID: 26275852
[TBL] [Abstract][Full Text] [Related]
32. [Occurrence of genotypes of porcine circovirus (PCV2) in pig farms using different vaccination strategies against PCV2].
Eddicks M; Szikora F; Walhöfer N; Sauter Louis C; Reese S; Banholzer E; Reiner G; Sutter G; Ritzmann M; Fux R
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2017 Apr; 45(2):90-97. PubMed ID: 28327779
[TBL] [Abstract][Full Text] [Related]
33. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines.
Bandrick M; Gutiérrez AH; Desai P; Rincon G; Martin WD; Terry FE; De Groot AS; Foss DL
Vet Immunol Immunopathol; 2020 May; 223():110034. PubMed ID: 32278900
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
35. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.
Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
Clin Vaccine Immunol; 2010 Dec; 17(12):1940-5. PubMed ID: 20926694
[TBL] [Abstract][Full Text] [Related]
36. Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South Korea.
Kang SJ; Kang H; You SH; Lee HJ; Lee N; Hyun BH; Cha SH
BMC Vet Res; 2020 Sep; 16(1):334. PubMed ID: 32928247
[TBL] [Abstract][Full Text] [Related]
37. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
38. Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo.
Patterson R; Eley T; Browne C; Martineau HM; Werling D
Vaccine; 2015 Nov; 33(46):6199-205. PubMed ID: 26476879
[TBL] [Abstract][Full Text] [Related]
39. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
Wang X; Jiang P; Li Y; Jiang W; Dong X
Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
[TBL] [Abstract][Full Text] [Related]
40. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
